Skip to Content

C 070 (Phenazoforte plus butabarbital 15 mg / hyoscyamine hydrobromide 0.3 mg / phenazopyridine hydrochloride 150 mg)

Generic Name: butabarbital/hyoscyamine/phenazopyridine

Pill imprint C 070 has been identified as Phenazoforte plus butabarbital 15 mg / hyoscyamine hydrobromide 0.3 mg / phenazopyridine hydrochloride 150 mg.

PhenazoForte Plus is used in the treatment of dysuria and belongs to the drug class urinary antispasmodics. There is positive evidence of human fetal risk during pregnancy. PhenazoForte Plus butabarbital 15 mg / hyoscyamine hydrobromide 0.3 mg / phenazopyridine hydrochloride 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Phenazoforte plus butabarbital 15 mg / hyoscyamine hydrobromide 0.3 mg / phenazopyridine hydrochloride 150 mg C 070
Discount Card Promo
Phenazoforte plus
Generic Name:
butabarbital/hyoscyamine/phenazopyridine
Imprint:
C 070
Strength:
butabarbital 15 mg / hyoscyamine hydrobromide 0.3 mg / phenazopyridine hydrochloride 150 mg
Color:
Red
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Urinary antispasmodics
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Creekwood Pharmaceutical, Inc.

More info Print Imprint Search

More about PhenazoForte Plus (butabarbital / hyoscyamine / phenazopyridine)

Consumer resources

Professional resources

Related treatment guides

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide